ASTRO, ASCO, and AUA Strongly Endorse Shortened Course Of IMRT For Primary Therapy

Moderately hypofractionated IMRT (radiation therapy delivered in 20 to 26 treatments instead of the conventional 40-44  treatments) has received strong endorsement from all of the major US organizations of physicians who treat prostate cancer.   Read more about this significant new guideline here.